Marina P. Kotyleva

Marina P. Kotyleva

Auto-generated profile, based on publicly available information

Marina P. Kotyleva

Institute of Experimental Medicine

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2022 in Experimental and Clinical Gastroenterology
Verified
Journal Article
Open access
PDF file
EEElena Igorevna Ermolenko
Elena Igorevna Ermolenko
MKM. P. Kotyleva
M. P. Kotyleva
ATAnna Tsapieva
Anna Tsapieva
AKA. B. Karaseva
A. B. Karaseva
ТБТхи Лан Ань Буй
Тхи Лан Ань Буй
SASuvorov N Alexander
Suvorov N Alexander
In this work, we compared composition of the intestinal microbiota of healthy volunteers and patients with irritable bowel syndrome (IBS) in Hanoi residents before and after therapy with a probiotic starter culture based on the bacteriocinogenic strain Enterococcus faecium L3 (L3), which is successfully used to correct dysbiosis and treat IBS in Russia.In IBS patients (IBS group) α-diversity was higher than in the control group (Healthy) and in IBS patients after probiotic therapy (IBS + L3 group). Phylogenetic analysis of the studied samples refl ected the division of the studied communities into 2 clusters, one of which grouped samples, mainly taken for IBS before therapy. Principal component analysis (PCoA) showed that most of the samples from the IBS group are located on the graph in a separate sector, far from the adjacent IBS + L3 and Нealthy samples.A study of the microbiome of Vietnamese patients with IBS after taking probiotic at the level of types (phyls) revealed a tendency towards an increase in the representation of Firmicutes. The introduction of L3 led to an increase in the population of members of the family Lachnospiraceae, such as butyrate- producing Roseburia and acetate-producing Blautia. At the same time, the percentage of staphylococci and bacteria belonging to the Enterobacteriaceae family was decreased. In addition to positive changes in the functioning of the gastrointestinal tract, revealed on the basis of clinical data, the features of the intestinal microbiota of IBS residents of Hanoi compared with healthy volunteers and in the same patients after probiotic therapy were revealed by metagenomic analysis of 16S rRNA genes. Positive shifts in the intestinal microbiome of IBS patients in Vietnam after therapy with a probiotic starter culture based on L3 do not fundamentally diff er from the previously described eff ects noted by the authors when using this probiotic in Russia, which creates the preconditions for expanding the possibility of its use in the Asian region.

17 June 2022 in HERALD of North-Western State Medical University named after I.I. Mechnikov
Verified
Journal Article
Open access
PDF file
NBNatalya V. Bakulina
Natalya V. Bakulina
STSergey V. Tikhonov
Sergey V. Tikhonov
EEElena Igorevna Ermolenko
Elena Igorevna Ermolenko
MKMarina P. Kotyleva
Marina P. Kotyleva
NLNadezhda S. Lavrenova
Nadezhda S. Lavrenova
ТВТихонов Сергей Викторович
Тихонов Сергей Викторович
BACKGROUND: Bacteria in the gastrointestinal tract regulate eating behavior and metabolic processes. A number of probiotic strains have a positive effect on glucose and insulin metabolism. A series of studies have demonstrated the effectiveness of autoprobiotic therapy in the treatment of patients with gastrointestinal diseases. The efficacy and safety of an indigenous strain of Enterococcus faecium in overweight patients with type 2 diabetes has not been studied in the past. AIM: To evaluate the effectiveness of products containing the probiotic strain Enterococcus faecium L3 or the indigenous strain Enterococcus faecium in patients with diabetes mellitus (DM) type 2. MATERIALS AND METHODS: Patients with diabetes mellitus type 2 were randomized into two groups: group of probiotic therapy with an industrial strain of Enterococcus faecium L3 (11 patients); group of autoprobiotic therapy based on an indigenous strain of Enterococcus faecium (9 patients). Therapy was for 14 days. Before and 10-14 days after the end of therapy, anthropometric parameters were assessed; psychometric testing was carried out; biochemical parameters of blood serum were studied. The intestinal microbiota was studied by real-time polymerase chain reaction. RESULTS: Probiotic therapy based on Enterococcus faecium L3 and autoprobiotic therapy based on indigenous Enterococcus faecium had no significant effect on glucose metabolism in patients with type 2 DM. In the Enterococcus faecium L3 group and the group of indigenous Enterococcus faecium there was a significant decrease in gastroenterological complaints on scales of the GSRS questionnaire. Patients in both groups showed a statistically significant decrease in the total bacterial mass, an increase in the quantitative content of Lactobacillus spp., a decrease in the population of Bifidobacterium spp. and Bacteroides thetaiotaomicron. CONCLUSIONS: The probiotic strain Enterococcus faecium L3 and the indigenous Enterococcus faecium do not have a significant effect on the metabolism of glucose and insulin, while they contribute to a similar change in the component composition of the microbiota and a decrease in the severity of gastroenterological complaints.

1 January 2022 in Russian Journal of Preventive Medicine
Verified
Journal Article
Closed access
NBN.V. Bakulina
N.V. Bakulina
STS.V. Tikhonov
S.V. Tikhonov
EEElena Igorevna Ermolenko
Elena Igorevna Ermolenko
MKM.P. Kotyleva
M.P. Kotyleva
NLN.S. Lavrenova
N.S. Lavrenova
ASAleksandr Suvorov
Aleksandr Suvorov
Количественная и качественная характеристика кишечной микробиоты определяет наличие и выраженность метаболических нарушений у пациентов с избыточной массой тела, ожирением и сахарным диабетом (СД) 2-го типа. ЦЕЛЬ ИССЛЕДОВАНИЯ Изучить количественные и качественные характеристики кишечной микробиоты, гастроэнтерологические жалобы и качество жизни пациентов с избыточной массой тела, ожирением и СД 2-го типа. МАТЕРИАЛ И МЕТОДЫ В исследование включен 51 пациент с избыточной массой тела, ожирением. Пациентам измеряли массу тела, рост, окружность талии; кишечную микробиоту изучали методом полимеразной цепной реакции в режиме реального времени; определяли содержание в сыворотке крови аланинаминотрансферазы, аспартатаминотрансферазы, щелочной фосфатазы, гамма-глутамилтранспептидазы, билирубина по фракциям, альбумина, глюкозы, инсулина, лактатдегидрогеназы, триглицеридов, общего холестерина, липопротеидов низкой плотности, липопротеидов высокой плотности, С-реактивного белка. Пациенты заполняли опросники GSRS, SF-36. Проведено сравнение характеристики кишечной микробиоты пациентов с избыточной массой тела и ожирением, пациентов с СД 2-го типа и без СД 2-го типа. Осуществлен поиск клинических, физикальных, лабораторных параметров, коррелирующих с концентрацией кишечных бактерий. РЕЗУЛЬТАТЫ В исследование включены 19 (37%) мужчин и 32 (63%) женщины. Медиана возраста составила 54 [44; 63] года, медиана индекса массы тела — 30,99 [28,62; 34,44] кг/м2. Абдоминальное ожирение выявлено у 46 (90,2%) пациентов, СД 2-го типа — у 28 (54,9%) пациентов. Различия между показателями у пациентов с СД 2-го типа и без него: общая бактериальная масса — 12,00 [10,00; 12,78] по сравнению с 10,78 [9,78; 11,48] (p=0,004); Lactobacillus spp. — 0,00 [0,00; 5,00] по сравнению с 5,00 [5,00; 5,70] (p<0,001); Escherichia coli — 8,30 [6,90; 9,00] по сравнению с 6,60 [6,30; 7,78] (p<0,001); Bacteroides spp. — 11,92 [10,70; 13,00] по сравнению с 10,78 [9,78; 11,30] (p<0,001); Bacteroides thetaiotaomicron — 7,30 [0,00; 9,00] по сравнению с 0,00 [0,00; 6,95] (p=0,010); Akkermansia muciniphila — 0,00 [0,00; 0,00] по сравнению с 6,30 [0,00; 8,48] log10 КОЕ/г (p=0,05). На фоне нарастания окружности талии уменьшалась концентрация в стуле Lactobacillus spp., нарастали концентрации E. coli, Bacteroides spp. и Staphylococcus aureus. Нарастание концентрации A. muciniphila и Lactobacillus spp. сопровождалось уменьшением биохимических маркеров метаболических нарушений. ЗАКЛЮЧЕНИЕ Результаты исследования показали, что концентрация ряда кишечных бактерий связана с наличием сахарного диабета 2-го типа и другими метаболическими расстройствами.

25 January 2026 in Experimental and Clinical Gastroenterology
Verified
Journal Article
Closed access
EEElena Igorevna Ermolenko
Elena Igorevna Ermolenko
NNN. S. Novikova
N. S. Novikova
MKM. P. Kotyleva
M. P. Kotyleva
AMA. V. Matsulevich
A. V. Matsulevich
A(Alena Zalicheva (Karaseva)
Alena Zalicheva (Karaseva)
IAI. N. Abdurasulova
I. N. Abdurasulova
The effect of autoprobiotics, indigenous nonpathogenic enterococci, and the indigenous consortium of microbes (ICM) obtained from fecal samples on the restoration of intestinal microbiocenosis and behavioral responses in male Wistar rats with intestinal dysbiosis induced by ampicillin and metronidazole was studied. The conditions used for fecal sample cultivation led to an increase in the proportion of lactobacilli and enterococci in the ICM. When analyzing the condition of animals, in particular, when evaluating motor and exploratory activity in the “open field” test, as well as the results of 16S rRNA sequencing after administration of autoprobiotics, the following were revealed: faster disappearance of dyspepsia, decreased signs of anxiety, and compensatory changes in the composition of the microbiota. The composition of the intestinal microbiome had significant differences in the animal groups depending on exposure after administration of antimicrobial drugs. Moreover, in the group that did not receive autoprobiotics, along with more pronounced signs of dysbiosis, signs of self-healing were revealed. The maximum changes in the intestinal microbiota and the effect on animal behavior were exerted by ICM. The revealed phenomena should be taken into account when developing methods of complex therapy of diseases accompanied by the development of dysbiotic conditions, especially with pronounced changes in the functioning of the central nervous system.

25 January 2026 in Experimental and Clinical Gastroenterology
Verified
Journal Article
Closed access
LALyubov Alferova
Lyubov Alferova
EPE. N. Pariyskaya
E. N. Pariyskaya
LZL. B. Zakharova
L. B. Zakharova
NNN. S. Novikova
N. S. Novikova
VOV. V. Orlova
V. V. Orlova
EEElena Igorevna Ermolenko
Elena Igorevna Ermolenko
The effect of probiotic and autoprobiotic (indigenous non-pathogenic) E. coli on intestinal motility and microbiota in experimental intestinal dysbiosis in male Wistar rats was studied. The administration of ampicillin and metronidazole led to a decrease in appetite, weight loss, and diarrhea. In animals with intestinal dysbiosis, there was a decrease in the amplitude of intestinal wall contractions and the amount of work performed by the smooth muscle cells of the intestinal wall, compared to the control group of intact animals (K2), accompanied by an increase in the population of Klebsiella and Bacteroides fragilis group. In contrast to the control group K1, which did not receive any treatment for dysbiosis, the administration of probiotic and autoprobiotic E. coli resulted in a decrease in the number of opportunistic pathogens and an increase in the number of fecalibacteria (butyrate producers). Changes in the microbiota contributed to the restoration of motor activity in the distal colon of rats.

25 January 2026 in Experimental and Clinical Gastroenterology
Verified
Journal Article
Closed access
GBG. M. Berdichevsky
G. M. Berdichevsky
NNN. S. Novikova
N. S. Novikova
STS. V. Tikhonov
S. V. Tikhonov
YTYu. G. Topalova
Yu. G. Topalova
MKM. P. Kotyleva
M. P. Kotyleva
EEElena Igorevna Ermolenko
Elena Igorevna Ermolenko